Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
Metastatic Tumor Research and Outcomes Network
NCT02830451 · View on ClinicalTrials.gov ↗
Study Summary
The registry aims to collect patient information such as patient demographics, co-morbidities, clinical, diagnostic, and therapeutic data, as well as information on adverse events and HRQOL outcomes specific for patients with metastatic spine tumor(s).
Conditions Studied
Study Locations (20)
New York
- Memorial Sloan-Kettering Cancer Center — New York
- University of Rochester School of Medicine and Dentistry Department of Orthopaedic Surgery and Neurosurgery — Rochester
Ontario
- Toronto Western Hospital Department of Neurosurgery Division of Surgery — Toronto
- University of Toronto Odette Cancer Centre - T2 158 Sunnybrook Health Sciences Ccenter — Toronto
California
- University of California The UCSF Spine Center Department of Neurological Surgery — San Francisco
Illinois
- Rush University Medical Center University Neurosurgery — Chicago
Maryland
- Johns Hopkins University Department of Neurosurgery / Spine Division — Baltimore
Massachusetts
- Harvard Medical School Department of Neurosurgery — Boston
Minnesota
- Mayo Clinic Department of Neurosurgery — Rochester
Pennsylvania
- Penn Presbyterian Medical Center Department of Neurosurgery — Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 960 participants |
| Start Date | 2017-11-15 |
| Est. Completion | 2026-08-15 |
Interested in This Trial?
Always speak with your doctor before enrolling in a clinical trial.
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02830451
The ClinicalTrials.gov registry entry for NCT02830451 describes a study currently listed as active not recruiting. It is categorized as an unspecified phase, which is the standard way researchers label where a study sits along the investigational pathway from early safety work through later efficacy and post-marketing evaluation. The registered enrollment target is 960 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AO Innovation Translation Center, which has 13 total studies on file at ClinicalTrials.gov, and sponsors are the parties responsible for study design, oversight, and regulatory filings.
The record links to 1 condition, with Metastatic Spine Tumor appearing as the primary indexed condition, and to 0 interventions. Interventions can include drugs, devices, procedures, behavioral programs, or observational arms, and each is tracked as a separate registry field so that downstream queries can filter accurately. When a trial lists multiple interventions, it usually reflects a multi-arm design or a comparison protocol rather than a single treatment being tested in isolation. The brief summary published in the registry is the clearest source of protocol intent and should be read before drawing conclusions from any sidebar tags.
Geographic footprint matters for practical reasons: NCT02830451 reports 20 study locations spanning 18 distinct geographic areas — top geographies include New York, Ontario, California. A larger site network tends to correlate with broader recruitment capacity, but it does not imply anything about study quality, and site-level enrollment status can diverge from the overall registry status shown above. Every data point on this page comes from the public ClinicalTrials.gov dataset and is reproduced here for reference only; it is not a medical recommendation, an endorsement of the sponsor, or an invitation to enroll. Verify current status, eligibility criteria, and contact details directly at ClinicalTrials.gov, and discuss any participation decision with your own healthcare provider.
Frequently Asked Questions
What is clinical trial NCT02830451 about?
NCT02830451 is a clinical study titled "Metastatic Tumor Research and Outcomes Network". The registry aims to collect patient information such as patient demographics, co-morbidities, clinical, diagnostic, and therapeutic data, as well as information on adverse events and HRQOL outcomes specific for patients with metastatic spine tumor(s).
What is the current status of trial NCT02830451?
This trial is currently active not recruiting. The enrollment target is 960 participants. The study started on 2017-11-15. Estimated completion is 2026-08-15.
What conditions does trial NCT02830451 study?
This clinical trial studies the following conditions: Metastatic Spine Tumor. These conditions were identified from the trial registry and reflect the primary focus areas of the research.
Who is sponsoring clinical trial NCT02830451?
This trial is sponsored by AO Innovation Translation Center, which has 13 total clinical trials registered on ClinicalTrials.gov. The sponsor is responsible for the study's design, funding, and regulatory compliance.
Where is trial NCT02830451 being conducted?
This trial has 20 study locations across California, Illinois, Maryland, Massachusetts, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How Clinical Trials Work
Understand phases 1-4, trial design, randomization, and the informed consent process.
Patient Rights in Clinical Trials
Your rights as a participant: consent, withdrawal, privacy, and who to contact.
Finding the Right Clinical Trial
A practical guide to searching trials, understanding eligibility, and evaluating options.
All Guides
Browse our complete library of clinical trial educational resources.
Read our methodology — how this data is sourced, computed, and verified.